BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 7589080)

  • 1. Induction of Th1 and Th2 CD4+ T cell responses by oral or parenteral immunization with ISCOMS.
    Maloy KJ; Donachie AM; Mowat AM
    Eur J Immunol; 1995 Oct; 25(10):2835-41. PubMed ID: 7589080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response.
    Bliss J; Van Cleave V; Murray K; Wiencis A; Ketchum M; Maylor R; Haire T; Resmini C; Abbas AK; Wolf SF
    J Immunol; 1996 Feb; 156(3):887-94. PubMed ID: 8558014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limiting dilution analysis of CD4 T-cell cytokine production in mice administered native versus polymerized ovalbumin: directed induction of T-helper type-1-like activation.
    Gieni RS; Yang X; Kelso A; Hayglass KT
    Immunology; 1996 Jan; 87(1):119-26. PubMed ID: 8666423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production.
    Kim TS; DeKruyff RH; Rupper R; Maecker HT; Levy S; Umetsu DT
    J Immunol; 1997 May; 158(9):4137-44. PubMed ID: 9126973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles.
    Maloy KJ; Donachie AM; O'Hagan DT; Mowat AM
    Immunology; 1994 Apr; 81(4):661-7. PubMed ID: 7518802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nontoxic Shiga toxin derivatives from Escherichia coli possess adjuvant activity for the augmentation of antigen-specific immune responses via dendritic cell activation.
    Ohmura M; Yamamoto M; Tomiyama-Miyaji C; Yuki Y; Takeda Y; Kiyono H
    Infect Immun; 2005 Jul; 73(7):4088-97. PubMed ID: 15972497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Priming or tolerization of the B- and Th2-dependent immune response by the oral administration of OVA-DNP is determined by the antigen dosage.
    Franco L; Benedetti R; Ferek GA; Massouh E; Fló J
    Cell Immunol; 1998 Nov; 190(1):1-11. PubMed ID: 9826441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diesel exhaust, carbon black, and silica particles display distinct Th1/Th2 modulating activity.
    van Zijverden M; van der Pijl A; Bol M; van Pinxteren FA; de Haar C; Penninks AH; van Loveren H; Pieters R
    Toxicol Appl Pharmacol; 2000 Oct; 168(2):131-9. PubMed ID: 11032768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of systemic and mucosal immune responses following immunization with somatostatin-avidin complexes incorporated into ISCOMS.
    Estrada A; Laarveld B; Li B; Redmond MJ
    Immunol Invest; 1995 Aug; 24(5):819-28. PubMed ID: 8543345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells retrovirally overexpressing IL-12 induce strong Th1 responses to inhaled antigen in the lung but fail to revert established Th2 sensitization.
    Kuipers H; Heirman C; Hijdra D; Muskens F; Willart M; van Meirvenne S; Thielemans K; Hoogsteden HC; Lambrecht BN
    J Leukoc Biol; 2004 Nov; 76(5):1028-38. PubMed ID: 15316032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of orally induced systemic unresponsiveness in IFN-gamma knockout mice.
    Kweon MN; Fujihashi K; VanCott JL; Higuchi K; Yamamoto M; McGhee JR; Kiyono H
    J Immunol; 1998 Feb; 160(4):1687-93. PubMed ID: 9469425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of methotrexate on Th1 and Th2 immune responses in mice.
    Yamaki K; Uchida H; Harada Y; Li X; Yanagisawa R; Takano H; Hayashi H; Taneda S; Mori Y; Yoshino S
    J Pharm Pharmacol; 2003 Dec; 55(12):1661-6. PubMed ID: 14738593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo IL-12 administration induces profound but transient commitment to T helper cell type 1-associated patterns of cytokine and antibody production.
    Rempel JD; Wang M; HayGlass KT
    J Immunol; 1997 Aug; 159(3):1490-6. PubMed ID: 9233648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of oral tolerance in the primed immune system: influence of antigen persistence and adjuvant form.
    Leishman AJ; Garside P; Mowat AM
    Cell Immunol; 2000 Jun; 202(2):71-8. PubMed ID: 10896766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological adjuvant effect of Boswellia serrata (BOS 2000) on specific antibody and cellular response to ovalbumin in mice.
    Gupta A; Khajuria A; Singh J; Singh S; Suri KA; Qazi GN
    Int Immunopharmacol; 2011 Aug; 11(8):968-75. PubMed ID: 21371582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 Th2 cells do not functionally suppress CTL generation in neonatal tolerant mice.
    Gao Q; Chen N; Field EH
    Transplantation; 1995 Dec; 60(11):1260-8. PubMed ID: 8525520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
    Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
    Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble protein but not peptide administration diverts the immune response of a clonal CD4+ T cell population to the T helper 2 cell pathway.
    Degermann S; Pria E; Adorini L
    J Immunol; 1996 Oct; 157(8):3260-9. PubMed ID: 8871620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella.
    VanCott JL; Staats HF; Pascual DW; Roberts M; Chatfield SN; Yamamoto M; Coste M; Carter PB; Kiyono H; McGhee JR
    J Immunol; 1996 Feb; 156(4):1504-14. PubMed ID: 8568254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cell depletion fails to influence initial CD4 T cell commitment in vivo in exogenous antigen-stimulated cytokine and antibody responses.
    Wang M; Ellison CA; Gartner JG; HayGlass KT
    J Immunol; 1998 Feb; 160(3):1098-105. PubMed ID: 9570522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.